Skip to main navigation
Skip to search
Skip to main content
University of Toyama Home
日本語
English
Home
Profiles
Research units
Projects
Research output
Datasets
Prizes
Activities
Courses
Search by expertise, name or affiliation
Clinical Implications of Ivabradine in the Contemporary Era
Teruhiko Imamura
*
*
Corresponding author for this work
Internal Medicine (2)
Research output
:
Contribution to journal
›
Review article
›
peer-review
1
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Clinical Implications of Ivabradine in the Contemporary Era'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Ivabradine
100%
Heart Rate
33%
Up-titration
33%
Heart Failure
22%
Beta-blockers
22%
Heart Failure with Preserved Ejection Fraction (HFpEF)
22%
E Wave
22%
Echocardiography Guided
22%
Alpha Wave
22%
Cardiac Reverse Remodeling
22%
Clinical Indications
22%
Clinical Outcomes
11%
Clinically Significant
11%
Cardiac Output
11%
Acute Heart Failure
11%
Sepsis
11%
Patients with Heart Failure
11%
Doppler Echocardiography
11%
Atrial Fibrillation
11%
Ion Channels
11%
Disease Spectrum
11%
Heart Rate Control
11%
Tachycardia
11%
Heart Rate Modulation
11%
Clinical Applicability
11%
Transmitral
11%
Sinus Rhythm
11%
Hemodynamic Stability
11%
Significant Benefit
11%
Stable Angina
11%
Potential Expansion
11%
Theory-driven
11%
Induced Hypotension
11%
Medicine and Dentistry
Ivabradine
100%
Congestive Heart Failure
33%
Titrimetry
33%
Echocardiography
22%
Beta Adrenergic Receptor Blocking Agent
22%
Disease
11%
Hemodynamic
11%
Heart Output
11%
Heart Failure with Preserved Ejection Fraction
11%
Heart Failure with Reduced Ejection Fraction
11%
Doppler Echocardiography
11%
Ion Channel
11%
Atrial Fibrillation
11%
Acute Decompensated Heart Failure
11%
Sinus Rhythm
11%
Sepsis
11%
Tachyarrhythmia
11%
Stable Angina Pectoris
11%
Induced Hypotension
11%
Pharmacology, Toxicology and Pharmaceutical Science
Ivabradine
100%
Congestive Heart Failure
33%
Beta Adrenergic Receptor Blocking Agent
22%
Disease
11%
Acute Heart Failure
11%
Sepsis
11%
Ion Channel
11%
Tachycardia
11%
Atrial Fibrillation
11%
Heart Failure with Reduced Ejection Fraction
11%
Hypotension
11%
Heart Failure with Preserved Ejection Fraction
11%
Stable Angina Pectoris
11%